{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:08Z","timestamp":1792173488097,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00520-026-10382-x","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T17:05:58Z","timestamp":1769533558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological interactions between psychotropic drugs and anticancer treatments: implications for clinical practice"],"prefix":"10.1007","volume":"34","author":[{"given":"Valerio","family":"Caruso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pacciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Antonuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Serafin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Zatteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Perugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"Suppl","key":"10382_CR1","first-page":"12","volume":"51","author":"MJ Massie","year":"1990","unstructured":"Massie MJ, Holland JC (1990) Depression and the cancer patient. J Clin Psychiatry 51(Suppl):12\u201319","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10382_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2000.18.4.893","volume":"18","author":"P Hopwood","year":"2000","unstructured":"Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18(4):893\u2013903. https:\/\/doi.org\/10.1200\/JCO.2000.18.4.893","journal-title":"J Clin Oncol"},{"issue":"2S","key":"10382_CR3","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/j.jmir.2023.01.007","volume":"54","author":"L Charlesworth","year":"2023","unstructured":"Charlesworth L, Fegan C, Ashmore R (2023) How does severe mental illness impact on cancer outcomes in individuals with severe mental illness and cancer? A scoping review of the literature. J Med Imaging Radiat Sci 54(2S):S104\u2013S114. https:\/\/doi.org\/10.1016\/j.jmir.2023.01.007","journal-title":"J Med Imaging Radiat Sci"},{"key":"10382_CR4","doi-asserted-by":"crossref","unstructured":"Sellick SJ, Crooks PA (1999) Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions. Psycho-Oncol 8(4):315\u2013333. https:\/\/doi.org\/10.1002\/(SICI)1099-1611(199907)8:4<315::AID-PON312>3.0.CO;2-R","DOI":"10.1002\/(SICI)1099-1611(199907\/08)8:4<315::AID-PON391>3.0.CO;2-G"},{"issue":"5","key":"10382_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/annonc\/mdq097","volume":"21","author":"S Singer","year":"2010","unstructured":"Singer S, Das-Munshi J, Br\u00e4hler E (2010) Prevalence of mental health conditions in cancer patients in acute care\u2013a meta-analysis. Ann Oncol 21(5):925\u2013930. https:\/\/doi.org\/10.1093\/annonc\/mdq097","journal-title":"Ann Oncol"},{"issue":"4","key":"10382_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1176\/ajp.151.4.537","volume":"151","author":"HM Chochinov","year":"1994","unstructured":"Chochinov HM, Wilson KG, Enns M, Lander S (1994) Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry 151(4):537\u2013540. https:\/\/doi.org\/10.1176\/ajp.151.4.537","journal-title":"Am J Psychiatry"},{"issue":"32","key":"10382_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jncimonographs\/lgh014","volume":"2004","author":"MJ Massie","year":"2004","unstructured":"Massie MJ (2004) Prevalence of depression in patients with cancer. JNCI Monogr 2004(32):57\u201371","journal-title":"JNCI Monogr"},{"key":"10382_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2016.11.004","volume":"52","author":"B Bortolato","year":"2017","unstructured":"Bortolato B, Hyphantis TN, Valpione S, Perini G, Maes M, Morris G, Kubera M, K\u00f6hler CA, Fernandes BS, Stubbs B, Pavlidis N, Carvalho AF (2017) Depression in cancer: the many biobehavioral pathways driving tumor progression. Cancer Treat Rev 52:58\u201370. https:\/\/doi.org\/10.1016\/j.ctrv.2016.11.004","journal-title":"Cancer Treat Rev"},{"issue":"13\u201314","key":"10382_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s10354-020-00739-0","volume":"170","author":"A Quante","year":"2020","unstructured":"Quante A, Schulz K, Fissler M (2020) Psychiatric comorbidities in cancer patients: acute interventions by the psychiatric consultation liaison service. Wien Med Wochenschr 170(13\u201314):348\u2013356. https:\/\/doi.org\/10.1007\/s10354-020-00739-0","journal-title":"Wien Med Wochenschr"},{"issue":"6","key":"10382_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1245\/s10434-012-2793-5","volume":"20","author":"O Arrieta","year":"2013","unstructured":"Arrieta O, Angulo LP, N\u00fa\u00f1ez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Mart\u00ednez-L\u00f3pez D, Alvarado S, Corona-Cruz JF, O\u00f1ate-Oca\u00f1a LF (2013) Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol 20(6):1941\u20131948. https:\/\/doi.org\/10.1245\/s10434-012-2793-5","journal-title":"Ann Surg Oncol"},{"issue":"9238","key":"10382_CR11","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/S0140-6736(00)02821-X","volume":"356","author":"M Colleoni","year":"2000","unstructured":"Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A (2000) Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet (London, England) 356(9238):1326\u20131327. https:\/\/doi.org\/10.1016\/S0140-6736(00)02821-X","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10382_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/bmjspcare-2012-000380","volume":"5","author":"P Fitzgerald","year":"2015","unstructured":"Fitzgerald P, Lo C, Li M, Gagliese L, Zimmermann C, Rodin G (2015) The relationship between depression and physical symptom burden in advanced cancer. BMJ Support Palliat Care 5(4):381\u2013388","journal-title":"BMJ Support Palliat Care"},{"issue":"2","key":"10382_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10549-015-3471-7","volume":"152","author":"BT Mausbach","year":"2015","unstructured":"Mausbach BT, Schwab RB, Irwin SA (2015) Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 152(2):239\u2013246. https:\/\/doi.org\/10.1007\/s10549-015-3471-7","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10382_CR14","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1200\/JCO.2002.07.101","volume":"20","author":"JM Prieto","year":"2002","unstructured":"Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, Gast\u00f3 C (2002) Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 20(7):1907\u20131917. https:\/\/doi.org\/10.1200\/JCO.2002.07.101","journal-title":"J Clin Oncol"},{"issue":"5","key":"10382_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jhm.2547","volume":"11","author":"JL Pederson","year":"2016","unstructured":"Pederson JL, Warkentin LM, Majumdar SR, McAlister FA (2016) Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: a systematic review and meta-analysis. J Hosp Med 11(5):373\u2013380. https:\/\/doi.org\/10.1002\/jhm.2547","journal-title":"J Hosp Med"},{"issue":"36","key":"10382_CR16","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1200\/JCO.2017.73.4947","volume":"35","author":"K Iglay","year":"2017","unstructured":"Iglay K, Santorelli ML, Hirshfield KM, Williams JM, Rhoads GG, Lin Y, Demissie K (2017) Impact of preexisting mental illness on all-cause and breast cancer-specific mortality in elderly patients with breast cancer. Journal of clinical oncology\u202f: official journal of the American Society of Clinical Oncology 35(36):4012\u20134018. https:\/\/doi.org\/10.1200\/JCO.2017.73.4947","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"Suppl-1","key":"10382_CR17","doi-asserted-by":"publisher","DOI":"10.2174\/17450179-v17-e211208-2021-HT2-1910-8","volume":"19","author":"L Grassi","year":"2023","unstructured":"Grassi L, McFarland D, Riba M (2023) The risk and the course of cancer among people with severe mental illness. Clin Pract Epidemiol Ment Health 19(Suppl-1):e174501792301032. https:\/\/doi.org\/10.2174\/17450179-v17-e211208-2021-HT2-1910-8","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"1","key":"10382_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-019-0469-7","volume":"18","author":"K Oechsle","year":"2019","unstructured":"Oechsle K, Ullrich A, Marx G, Benze G, Heine J, Dickel LM, Zhang Y, Wowretzko F, Wendt KN, Nauck F, Bokemeyer C, Bergelt C (2019) Psychological burden in family caregivers of patients with advanced cancer at initiation of specialist inpatient palliative care. BMC Palliat Care 18(1):102. https:\/\/doi.org\/10.1186\/s12904-019-0469-7","journal-title":"BMC Palliat Care"},{"issue":"9","key":"10382_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0393-0","volume":"15","author":"R Caruso","year":"2013","unstructured":"Caruso R, Grassi L, Nanni MG, Riba M (2013) Psychopharmacology in psycho-oncology. Curr Psychiatry Rep 15(9):393. https:\/\/doi.org\/10.1007\/s11920-013-0393-0","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"10382_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/09540261.2013.869436","volume":"26","author":"BR Cassileth","year":"2014","unstructured":"Cassileth BR (2014) Psychiatric benefits of integrative therapies in patients with cancer. Int Rev Psychiatry 26(1):114\u2013127. https:\/\/doi.org\/10.3109\/09540261.2013.869436","journal-title":"Int Rev Psychiatry"},{"issue":"10","key":"10382_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/pon.5415","volume":"29","author":"L Grassi","year":"2020","unstructured":"Grassi L, Riba M (2020) Cancer and severe mental illness: bi-directional problems and potential solutions. Psycho-Oncol 29(10):1445\u20131451. https:\/\/doi.org\/10.1002\/pon.5415","journal-title":"Psycho-Oncol"},{"issue":"3","key":"10382_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011006","volume":"3","author":"G Vita","year":"2023","unstructured":"Vita G, Compri B, Matcham F, Barbui C, Ostuzzi G (2023) Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev 3(3):CD011006. https:\/\/doi.org\/10.1002\/14651858.CD011006","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10382_CR23","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.4088\/JCP.08r04856blu","volume":"70","author":"JE Desmarais","year":"2009","unstructured":"Desmarais JE, Looper KJ (2009) Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry 70(12):1688\u20131697. https:\/\/doi.org\/10.4088\/JCP.08r04856blu","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10382_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2354.2009.01113.x","volume":"20","author":"KY Yap","year":"2011","unstructured":"Yap KY, Tay WL, Chui WK, Chan A (2011) Clinically relevant drug interactions between anticancer drugs and psychotropic agents. Eur J Cancer Care 20(1):6\u201332. https:\/\/doi.org\/10.1111\/j.1365-2354.2009.01113.x","journal-title":"Eur J Cancer Care"},{"issue":"4","key":"10382_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/10781552221079786","volume":"28","author":"C Daignault","year":"2022","unstructured":"Daignault C, Sauer HE, Lindsay H, Alonzo A, Foster J (2022) Investigating potential drug-drug interactions in pediatric and adolescent patients receiving chemotherapy. J Oncol Pharm Pract 28(4):904\u2013909. https:\/\/doi.org\/10.1177\/10781552221079786","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"10382_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1517\/17425255.2012.659840","volume":"8","author":"A Chan","year":"2012","unstructured":"Chan A, Ng TR, Yap KY (2012) Clinically-relevant anticancer-antidepressant drug interactions. Expert Opin Drug Metab Toxicol 8(2):173\u2013199. https:\/\/doi.org\/10.1517\/17425255.2012.659840","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10382_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"10382_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/10781552241255140","author":"A Albayrak","year":"2024","unstructured":"Albayrak A, Erbay B, Kay\u0131k\u00e7\u0131o\u011flu E (2024) Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer. J Oncol Pharm Pract. https:\/\/doi.org\/10.1177\/10781552241255140","journal-title":"J Oncol Pharm Pract"},{"key":"10382_CR29","doi-asserted-by":"publisher","unstructured":"Kuhn, K. H., Oliveira, M. R. F., Ribas, M. R., Zimmermann, P. R., & Silva, T. M. (2021). Use of antidepressants and potential drug interactions in cancer patients treated at a hospital in Southern Brazil. Revista de Epidemiologia e Controle de Infec\u00e7\u00e3o, 11(1). https:\/\/doi.org\/10.17058\/reci.v1i1.14587","DOI":"10.17058\/reci.v1i1.14587"},{"issue":"1","key":"10382_CR30","doi-asserted-by":"publisher","DOI":"10.4081\/mi.2019.8115","volume":"11","author":"JJ Wedret","year":"2019","unstructured":"Wedret JJ, Tu TG, Paul D, Rousseau C, Bonta A, Bota RG (2019) Interactions between antidepressants, sleep aids and selected breast cancer therapy. Ment Illn 11(1):8115. https:\/\/doi.org\/10.4081\/mi.2019.8115","journal-title":"Ment Illn"},{"issue":"2","key":"10382_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00520-017-3876-4","volume":"26","author":"S Sanjida","year":"2018","unstructured":"Sanjida S, Mulvogue K, Shaw J, Couper J, Kissane D, Pearson SA, Price MA, Janda M (2018) What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed? A retrospective case-control study at an Australian tertiary hospital. Support Care Cancer 26(2):625\u2013634. https:\/\/doi.org\/10.1007\/s00520-017-3876-4","journal-title":"Support Care Cancer"},{"issue":"2","key":"10382_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/2237-6089-2015-0003","volume":"37","author":"CdeA Reinert","year":"2015","unstructured":"Reinert CdeA, Ribas MR, Zimmermann PR (2015) Drug interactions between antineoplastic and antidepressant agents: analysis of patients seen at an oncology clinic at a general hospital. Trends Psychiatry Psychother 37(2):87\u201393. https:\/\/doi.org\/10.1590\/2237-6089-2015-0003","journal-title":"Trends Psychiatry Psychother"},{"key":"10382_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c693","volume":"340","author":"CM Kelly","year":"2010","unstructured":"Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, Paszat LF (2010) Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population-based cohort study. BMJ 340:c693. https:\/\/doi.org\/10.1136\/bmj.c693","journal-title":"BMJ"},{"key":"10382_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/CIO.S4381","volume":"4","author":"CF Sharpley","year":"2010","unstructured":"Sharpley CF, Bitsika V, Christie DRH (2010) Psychological distress among prostate cancer patients: fact or fiction? Clin Med Insights Oncol 4:11\u201320. https:\/\/doi.org\/10.4137\/CIO.S4381","journal-title":"Clin Med Insights Oncol"},{"key":"10382_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1218","volume":"360","author":"Y Park","year":"2018","unstructured":"Park Y, Bateman BT, Kim DH, Hernandez-Diaz S, Patorno E, Glynn RJ, Mogun H, Huybrechts KF (2018) Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study. BMJ 360:k1218. https:\/\/doi.org\/10.1136\/bmj.k1218","journal-title":"BMJ"},{"key":"10382_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11096-018-0724-7","volume":"41","author":"A Chastang","year":"2019","unstructured":"Chastang A, Renet S, Corny J, Beaussier H, Petre A, Lillo-Lelouet A, B\u00e9zie Y (2019) Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs. Int J Clin Pharm 41:42\u201348","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"10382_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21923","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A (2023) Colorectal cancer statistics, 2023. CA Cancer J Clin 73(3):233\u2013254. https:\/\/doi.org\/10.3322\/caac.21923","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10382_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","volume":"18","author":"Q Wang","year":"2023","unstructured":"Wang Q, G\u00fcm\u00fc\u015f ZH, Colarossi C, Memeo L, Wang X, Kong CY, Boffetta P (2023) SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection. J Thorac Oncol 18(1):31\u201346. https:\/\/doi.org\/10.1016\/j.jtho.2022.10.002","journal-title":"J Thorac Oncol"},{"key":"10382_CR39","unstructured":"World Health Organization. (2024, March). Breast cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer"},{"issue":"27","key":"10382_CR40","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","volume":"27","author":"JX Hu","year":"2021","unstructured":"Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F (2021) Pancreatic cancer: a review of epidemiology, trend, and risk factors. World J Gastroenterol 27(27):4298\u20134321. https:\/\/doi.org\/10.3748\/wjg.v27.i27.4298","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10382_CR41","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155","journal-title":"Cancer Res"},{"issue":"10174","key":"10382_CR42","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0140-6736(19)30269-4","volume":"393","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Montorsi F (2019) Renal cancer. Lancet 393(10174):1113\u20131126. https:\/\/doi.org\/10.1016\/S0140-6736(19)30269-4","journal-title":"Lancet"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10382-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:02:56Z","timestamp":1771272176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10382-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10382"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10382-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}